1. Home
  2. SDGR vs EQC Comparison

SDGR vs EQC Comparison

Compare SDGR & EQC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SDGR
  • EQC
  • Stock Information
  • Founded
  • SDGR 1990
  • EQC 1986
  • Country
  • SDGR United States
  • EQC United States
  • Employees
  • SDGR N/A
  • EQC N/A
  • Industry
  • SDGR Biotechnology: Pharmaceutical Preparations
  • EQC Real Estate Investment Trusts
  • Sector
  • SDGR Health Care
  • EQC Real Estate
  • Exchange
  • SDGR Nasdaq
  • EQC Nasdaq
  • Market Cap
  • SDGR 1.8B
  • EQC 2.2B
  • IPO Year
  • SDGR 2020
  • EQC 1986
  • Fundamental
  • Price
  • SDGR $19.96
  • EQC $1.61
  • Analyst Decision
  • SDGR Buy
  • EQC
  • Analyst Count
  • SDGR 7
  • EQC 0
  • Target Price
  • SDGR $32.29
  • EQC N/A
  • AVG Volume (30 Days)
  • SDGR 891.3K
  • EQC 734.9K
  • Earning Date
  • SDGR 04-30-2025
  • EQC 04-30-2025
  • Dividend Yield
  • SDGR N/A
  • EQC N/A
  • EPS Growth
  • SDGR N/A
  • EQC N/A
  • EPS
  • SDGR N/A
  • EQC 0.26
  • Revenue
  • SDGR $207,539,000.00
  • EQC $57,570,000.00
  • Revenue This Year
  • SDGR $28.69
  • EQC N/A
  • Revenue Next Year
  • SDGR $14.95
  • EQC N/A
  • P/E Ratio
  • SDGR N/A
  • EQC $6.10
  • Revenue Growth
  • SDGR N/A
  • EQC N/A
  • 52 Week Low
  • SDGR $16.67
  • EQC $1.40
  • 52 Week High
  • SDGR $29.15
  • EQC $21.00
  • Technical
  • Relative Strength Index (RSI)
  • SDGR 39.05
  • EQC 31.40
  • Support Level
  • SDGR $21.34
  • EQC $1.59
  • Resistance Level
  • SDGR $22.85
  • EQC $1.62
  • Average True Range (ATR)
  • SDGR 1.14
  • EQC 0.02
  • MACD
  • SDGR -0.21
  • EQC 0.03
  • Stochastic Oscillator
  • SDGR 5.06
  • EQC 37.50

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

About EQC Equity Commonwealth of Beneficial Interest

Equity Commonwealth is a real estate investment trust engaged in the acquisition, ownership, and operation of office buildings located throughout the United States. The vast majority of the company's real estate portfolio comprises office assets. These properties are fairly evenly dispersed between many of America's urban markets, notably Washington, Austin, and Denver. Equity Commonwealth derives the vast majority of its income in the form of rental revenue from tenants occupying its offices.

Share on Social Networks: